Integrating prevention of mother-to-child HIV transmission into antenatal care: learning from the experiences of women in South Africa

AIDS Care. 2004 Jan;16(1):37-46. doi: 10.1080/09540120310001633958.

Abstract

In 1999, for the first time in South Africa, a Mother-to-Child HIV Transmission (MTCT) prevention programme was implemented at the routine primary care level and not as part of a research protocol. A total of 264 women attending prenatal care in these clinics were interviewed in Xhosa using a standardized questionnaire. All had been offered HIV testing, and 95% had accepted. Women who had not been tested were four times more likely to believe that in the community families reject HIV-positive women (p<0.005). Of women who tested, 19% were HIV positive and 83% had told their partner that they had taken the test. HIV-positive women who had not disclosed testing to their partners were three times more likely to believe that, in the community, partners are violent towards HIV-positive women (p<0.005); 86% stated that they would have taken AZT if found to be HIV positive. Only 11% considered that the use of formula feeding indicated that a woman was HIV positive. In conclusion, routine prenatal HIV testing and interventions to reduce perinatal HIV transmission are acceptable to the majority of women in a South African urban township, despite an awareness of discrimination in the community towards HIV-positive women.

MeSH terms

  • Adult
  • Anti-HIV Agents / therapeutic use
  • Attitude to Health
  • Breast Feeding
  • Cross-Sectional Studies
  • Female
  • HIV Infections / prevention & control
  • HIV Infections / transmission*
  • Humans
  • Infectious Disease Transmission, Vertical / prevention & control*
  • Postnatal Care / methods
  • Pregnancy
  • Pregnancy Complications, Infectious / prevention & control*
  • Prenatal Care / methods*
  • South Africa
  • Truth Disclosure
  • Urban Population
  • Women's Health Services / organization & administration*
  • Zidovudine / therapeutic use

Substances

  • Anti-HIV Agents
  • Zidovudine